Dr. Wall joined The Hospital for Sick Children (SickKids) and University of Toronto in the fall of 2016 as Section Head of the Blood and Marrow Transplant/Cellular Therapy program. After completing paediatric and paediatric hematology/oncology training in New York and Boston she went on to establish BMT and public cord blood banks in St. Louis and San Antonio. Most recently she has led the Manitoba Blood and Marrow Transplant program including the Manitoba Center for Advanced Cell and Tissue Therapy. She has chaired the hematopoietic stem cell transplant discipline in the Children’s Oncology Group and holds leadership positions in the Paediatric Blood and Marrow Transplant Group, the Canadian Blood and Marrow Transplant Group and the CIHR-funded Canadian National Transplant Research program. Her research has focused on improving the outcomes of children undergoing transplant through a better understanding of the role of the innate immune system and the interaction between donor immune cells and their new environment both during the establishment of hematopoiesis/tolerance and as a tool to treat leukemia. She works with the entire BMT/CT program on early phase clinical trials exploring gene therapy trials for hemoglobinopathies and chimeric-antigen receptor T cell therapy for childhood acute leukemia.
Donna Wall MD, CCPE
The Hospital for Sick Children
Peter Gilgan Centre for Research and Learning
686 Bay St. 14.9400
Toronto, ON, M5G 0A4
Grad Students Must First Apply Through Department